Bayer's third-quarter sales came in a bit higher than anticipated, but the company is girding its loins for a challenging period ahead as generic competition and litigation liabilities bed in. Pharma ...

At the end of July, and before the company’s quarterly earnings report coming on Aug. 6, Bayer announced it has allocated an additional $1.37 billion to its efforts around glyphosate litigation. The ...

Heading into the second half of their 2025 financial year, Bayer leaders echo positive comments surrounding the company’s crop science division. What has them bullish? First, Bayer is optimistic the ...

If you're interested in exploring more stocks under $100 get an edge over other traders with Benzinga Pro while we're currently offering a 14-day trial. Do you think that you can’t start investing ...